GS-9256

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GS-9256, covering 2012-05-31 to 2014-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C [Phase 2]

See pricing